ADURO BIOTECH, INC. (ADRO) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 440 transactions totaling $39.2M, demonstrating a bearish sentiment with -$18.3M in net insider flow. The most recent transaction on Sep 15, 2020 involved a sale of 2,396 shares valued at $5.7K.
No significant insider buying has been recorded for ADRO in the recent period.
No significant insider selling has been recorded for ADRO in the recent period.
Based on recent SEC filings, insider sentiment for ADRO is bearish with an Insider Alignment Score of 27/100 and a net flow of -$18.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ADURO BIOTECH, INC. (ADRO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading ADRO stock, having executed 440 transactions in the past 90 days. The most active insider is Stephen T. Isaacs (Executive), who has made 95 transactions totaling $10.4M.
Get notified when executives and directors at ADRO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 15, 2020 | Ferber Celeste | Executive | Sale | 2,396 | $2.39 | $5.7K | |
| Sep 15, 2020 | Templeman Blaine | Executive | Sale | 12,369 | $2.39 | $29.6K | |
| Sep 15, 2020 | T. Isaacs Stephen | Executive | Sale | 32,481 | $2.39 | $77.6K | |
| Aug 7, 2020 | Ferber Celeste | Executive | Sale | 7,951 | $2.55 | $20.3K | |
| Aug 7, 2020 | Templeman Blaine | Executive | Sale | 7,951 | $2.55 | $20.3K | |
| Aug 7, 2020 | Sa Nuyten Dimitry | Executive | Sale | 3,538 | $2.55 | $9.0K | |
| Jun 1, 2020 | Templeman Blaine | Executive | Award | 22,500 | $N/A | $0 | |
| Jun 1, 2020 | Sa Nuyten Dimitry | Executive | Award | 10,000 | $N/A | $0 | |
| Jun 1, 2020 | Haghighat Ross | Executive | Award | 34,124 | $N/A | $0 | |
| Jun 1, 2020 | Ferber Celeste | Executive | Award | 22,500 | $N/A | $0 | |
| Jun 1, 2020 | G. Kachioff William | Executive | Award | 10,000 | $N/A | $0 | |
| Mar 18, 2020 | T. Isaacs Stephen | Executive | Option Exercise | 21,618 | $0.45 | $9.7K | |
| Mar 18, 2020 | Mariner Greenman William | Executive | Option Exercise | 19,835 | $0.45 | $8.9K | |
| Feb 25, 2020 | Andrea Van Elsas | Executive | Sale | 6,823 | $3.51 | $23.9K | |
| Jan 3, 2020 | Andrea Van Elsas | Executive | Sale | 73,311 | $1.19 | $87.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 191 | $28.7M | 69.6% |
Purchase(P) | 8 | $10.4M | 25.3% |
Exercise(M) | 150 | $2.0M | 5.0% |
Exercise (Options)(X) | 9 | $74.0K | 0.2% |
Award(A) | 32 | $0 | 0.0% |
Other(J) | 3 | $0 | 0.0% |
Gift(G) | 5 | $0 | 0.0% |
Conversion(C) | 42 | $0 | 0.0% |
Insider selling pressure at ADURO BIOTECH, INC. has increased, with 17 insiders executing 440 transactions across all time. Total sales of $28.7M significantly outpace purchases of $10.4M, resulting in a net outflow of $18.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.